Sometimes in investing we can find opportunities in sobering statistics. On a global scale, diabetes is reaching epidemic proportions with an estimated 285 million suffers worldwide. In America, nearly 24 million residents have been diagnosed and that number is expected to grow by an additional 12 million by 2020. Costs for diabetes care in the United States alone are estimated to be over $218 billion. Whatever the reason for this growing worldwide trend, (increasing sedentary lifestyle, food choices etc.) opportunities exist for investors in the companies that are working towards a cure or treat diabetes. (Perform a thorough checkup to uncover a medical stock with a clean bill of health. To learn more, see Investing In The Healthcare Sector.)

IN PICTURES: 6 Hot Careers With Lots Of Jobs

Long-Term Trend
The National Institute of Health estimates that obesity and related complications such as diabetes are our nation's chief health concern. There are nearly 133 million Americans that are currently considered overweight. This puts them at risk for the quickly growing Adult Onset or Type II Diabetes. The trend is a worldwide phenomenon. The World Health Organization research shows that more than 1 billion adults are overweight and at least 300 million of them clinically obese. As the world moves towards less physical activity and increased consumption of nutritionally deficient foods with higher levels of sugar and saturated fats, obesity rates and its complications will continue to rise, globally. This increase is often faster in developing countries. India is projected to have the most diabetes cases globally by the end of 2025.

A Portfolio Play
As we live longer, healthcare as a long-term trend makes sense despite the recent shake-ups regarding healthcare reform. Broad based exchange traded funds such as the Health Care Select Sector SPDR (NYSE:XLV) or the iShares Dow Jones U.S. Pharmaceuticals (NYSE:IHE) are good ways to play the sector. Since the HealthShares specific funds are no longer traded, investors wanting diabetes exclusive exposure need to look at individual companies. Here are a few picks.

One of the tragic effects of diabetes is the potential for kidney failure. Millions of people around the world suffer from this condition. Both DaVita (NYSE:DVA) and Fresenius Medical Care AG (NYSE:FMS) own and operate kidney dialysis centers. DaVita primarily focuses on the United States, while Fresenius operates around the world. Fresenius is also one of the chief producers of heparin, a blood thinner used in the dialysis.

Medical Devices
The diabetes sub-sector is the largest market for medical devices, growing from $12.4 billion in 2000 to current levels of nearly $27 billion today. Investors can play the device angle through several avenues from syringe manufacturers like Retractable Technologies (NYSE:RVP) and West Pharmaceutical (NYSE:WST), glucose monitors through Becton; Dickinson and Company (NYSE:BDX) or cutting edge insulin pumps through Medtronic (NYSE:MDT).

Diabetes Drugs
While there are several new therapy's in the works for diabetes care, insulin still remains at the bread and butter of the industry. Novo Nordisk (NYSE:NVO) became one of the first manufacturers of insulin in 1923 and currently supplies more than half of the worlds dosage. The company represents a pure drug player in the diabetes ring without the biotech stock risk.

The Bottom Line
Sadly, diabetes is quickly becoming a global epidemic. Nearly 300 million people suffer from the disease worldwide. As inactivity and high fat diets continue to seep into our lifestyles, the problem will compound them selves. Within these grim statistics, investors can find opportunities with the companies that are fighting this epidemic. The previous stocks represent a good starting point for further research. (Don't assume you're insured. Find out what you can expect from this healthcare program. For further reading, see What Does Medicare Cover?)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

Related Articles
  1. Investing News

    Bank Stocks: Time to Buy or Avoid? (WFC, JPM, C)

    Bank stocks have been pounded. Is this the right time to buy or should they be avoided?
  2. Stock Analysis

    Why the Bullish Are Turning Bearish

    Banks are reducing their targets for the S&P 500 for 2016. Here's why.
  3. Stock Analysis

    How to Find Quality Stocks Amid the Wreckage

    Finding companies with good earnings and hitting on all cylinders in this environment, although possible, is not easy.
  4. Chart Advisor

    How Are You Trading The Breakdown In Growth Stocks? (VOOG, IWF)

    Based on the charts of these two ETFs, bearish traders will start turning their attention to growth stocks.
  5. Mutual Funds & ETFs

    Pimco’s Top Funds for Retirement Income

    Once you're living off the money you've saved for retirement, is it invested in the right assets? Here are some from PIMCO that may be good options.
  6. Chart Advisor

    Watch This ETF For Signs Of A Reversal (BCX)

    Trying to determine if the commodity markets are ready for a bounce? Take a look at the analysis of this ETF to find out if now is the time to buy.
  7. Investing News

    What You Can Learn from Carl Icahn's Mistakes

    Carl Icahn has been a stellar performer in the investment world for decades, but following his lead these days could be dangerous.
  8. Mutual Funds & ETFs

    ETFs Can Be Safe Investments, If Used Correctly

    Learn about how ETFs can be a safe investment option if you know which funds to choose, including the basics of both indexed and leveraged ETFs.
  9. Mutual Funds & ETFs

    The Top 5 Large Cap Core ETFs for 2016 (VUG, SPLV)

    Look out for these five ETFs in 2016, and learn why investors should closely watch how the Federal Reserve moves heading into the new year.
  10. Economics

    India: Why it Might Pay to Be Bullish Right Now

    Many investors are bullish on India for all the right reasons. Does it present an investing opportunity?
  1. Should mutual funds be subject to more regulation?

    Mutual funds, when compared to other types of pooled investments such as hedge funds, have very strict regulations. In fact, ... Read Full Answer >>
  2. Do ETFs pay capital gains?

    Exchange-traded funds (ETFs) can generate capital gains that are transferred to shareholders, typically once a year, triggering ... Read Full Answer >>
  3. How do real estate hedge funds work?

    A hedge fund is a type of investment vehicle and business structure that aggregates capital from multiple investors and invests ... Read Full Answer >>
  4. Are Vanguard ETFs commission-free?

    While some Vanguard exchange-traded funds (ETFs) are available commission-free from third-party brokers, a large portion ... Read Full Answer >>
  5. Do Vanguard ETFs require a minimum investment?

    Vanguard completely waives any U.S. dollar minimum amounts to buy its exchange-traded funds (ETFs), and the minimum ETF investment ... Read Full Answer >>
  6. Can mutual fund expense ratios be negative?

    Mutual fund expense ratios cannot be negative. An expense ratio is the sum total of all fees charged by an asset management ... Read Full Answer >>
Trading Center